학술논문

Phase Ib/II trial of tipapkinogene sovacivec, a therapeutic human papillomavirus16-vaccine, in combination with avelumab in patients with advanced human papillomavirus16-positive cancers
Document Type
Article
Source
In: European Journal of Cancer. (European Journal of Cancer, September 2023, 191)
Subject
Language
English
ISSN
18790852
09598049